Dietary Interventions for Cancer
Trial Summary
What is the purpose of this trial?
This pilot trial will study the potential impact of two distinct dietary interventions with sequential use of high-fermented foods and high-fiber supplements on the gut microbiome and antitumor immunity in patients with melanoma and non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors. The trial aims to understand how dietary changes affect the composition and function of the gut microbiome, together with immunological and metabolomic markers in serum in patients with melanoma and NSCLC who are undergoing standard-of-care treatment with a PD-1/PD-L1 Inhibitors (neoadjuvant, adjuvant or consolidation)
Will I have to stop taking my current medications?
The trial requires you to stop taking certain medications, such as systemic antibiotics, corticosteroids, cytokines, methotrexate, immunosuppressive agents, and probiotics or fiber supplements, at least 14 days before starting the diet. Additionally, systemic antibiotics and proton pump inhibitors must be discontinued more than 21 days prior to the study.
What data supports the effectiveness of the treatment Dietary Interventions, High-Fermented Food Diet, High-Fiber Supplements for cancer?
Research suggests that high fiber intake, particularly from vegetables, may be linked to lower colon cancer rates, and fiber fermentation in the gut produces beneficial compounds that could help prevent cancer. However, the evidence is mixed, and more studies are needed to fully understand the effects.12345
Is it safe to use dietary interventions like high-fiber supplements and fermented foods for cancer prevention?
Research shows that while some dietary fibers may help reduce cancer risk, others, especially fermentable fibers, might increase tumor development in certain conditions. Additionally, some soluble fibers have been linked to liver issues and cancer in animal studies, so more research is needed to fully understand their safety.24567
How does the dietary intervention treatment for cancer differ from other treatments?
Research Team
Hassane M Zarour, MD
Principal Investigator
UPMC Hillman Cancer Center
Eligibility Criteria
This trial is for melanoma and NSCLC cancer patients undergoing standard immune checkpoint inhibitor therapy. It's designed to see if certain diets can help their treatment work better.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
High-Fermented Food Diet
Participants consume a high-fermented food diet to study its impact on gut microbiome and systemic inflammation
Break/Observation
Participants have a break period where they can eat any type of food without dietary restrictions
High-Fiber Supplementation
Participants receive high-fiber supplementation to study its impact on gut microbiome and systemic inflammation
Break/Observation
Participants have a break period where they can eat any type of food without dietary restrictions
Follow-up
Participants are monitored for safety and effectiveness after dietary interventions
Treatment Details
Interventions
- Dietary Interventions
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor